Hormonal strategies for the prevention of breast cancer.
Olsen
M R
MR
Cancer Prevention Program, University of Wisconsin, 7C Medical Sciences Center, Madison 53706, USA.
Love
R R
RR
D000818:Animals; D016588:Anticarcinogenic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000209:etiology / Q000517:prevention & control*; D002454:Cell Differentiation; D002471:Cell Transformation, Neoplastic; D002986:Clinical Trials as Topic; D003043:Cocarcinogenesis; D003278:Contraceptives, Oral, Hormonal / Q000627:therapeutic use; D004198:Disease Susceptibility; D004357:Drug Synergism; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D004967:Estrogens; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006801:Humans; D008954:Models, Biological; D009376:Neoplasms, Hormone-Dependent / Q000209:etiology / Q000517:prevention & control*; D010060:Ovulation / Q000187:drug effects; D011372:Progestins / Q000037:antagonists & inhibitors; D051381:Rats; D011960:Receptors, Estrogen / Q000187:drug effects; D017584:Reproductive History; D012176:Retinoids / Q000627:therapeutic use*; D013629:Tamoxifen / Q000627:therapeutic use
D016588:Anticarcinogenic Agents; D018931:Antineoplastic Agents, Hormonal; D003278:Contraceptives, Oral, Hormonal; D004965:Estrogen Antagonists; D004967:Estrogens; D011372:Progestins; D011960:Receptors, Estrogen; D012176:Retinoids; D013629:Tamoxifen; D007987:Gonadotropin-Releasing Hormone